February 27, 2018 / 10:27 PM / in 3 months

BRIEF-Heron Therapeutics Qtrly Net Loss Per Share $1.09

Feb 27 (Reuters) - Heron Therapeutics Inc:

* HERON THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2017 AND RECENT CORPORATE PROGRESS

* QTRLY BASIC AND DILUTED NET LOSS PER SHARE $1.09

* QTRLY NET PRODUCT SALES $10.1 MILLION VERSUS $1.3 MILLION

* Q4 EARNINGS PER SHARE VIEW $-0.79, REVENUE VIEW $9.3 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below